OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.
作者信息
Yang Yunxing, Xu Qingye, Li Tingting, Fu Ying, Shi Yue, Lan Peng, Zhao Dongdong, Chen Qiong, Zhou Zhihui, Jiang Yan, Peleg Anton Y, Yu Yunsong
机构信息
Department of Infectious Disease, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China.
出版信息
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01676-18. Print 2019 Jan.
Abstract
摘要
相似文献
1
OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.OXA-23是导致多种鲍曼不动杆菌临床菌株对舒巴坦耐药的常见机制。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01676-18. Print 2019 Jan.
2
Emergence of OXA-72-producing Acinetobacter baumannii Belonging to High-Risk Clones (CC15 and CC79) in Different Brazilian States.在巴西不同州出现产OXA-72的鲍曼不动杆菌，该菌属于高风险克隆群（CC15和CC79）
Infect Control Hosp Epidemiol. 2017 Feb;38(2):252-254. doi: 10.1017/ice.2016.287. Epub 2016 Dec 6.
3
4
[Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].[多黏菌素/舒巴坦联合用药对耐碳青霉烯类鲍曼不动杆菌菌株的疗效评估]
Mikrobiyol Bul. 2016 Jul;50(3):460-5. doi: 10.5578/mb.26289.
5
Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii.鲍曼不动杆菌临床分离株对舒巴坦联合新型β-内酰胺酶抑制剂 ETX2514 自发耐药的频率和机制。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01576-17. Print 2018 Feb.
6
Analysis of drug-resistant gene detection of blaOXA-like genes from Acinetobacter baumannii.鲍曼不动杆菌blaOXA样基因的耐药基因检测分析
Genet Mol Res. 2015 Dec 29;14(4):18999-9004. doi: 10.4238/2015.December.29.7.
7
Relationship between Tolerance and Persistence Mechanisms in Acinetobacter baumannii Strains with AbkAB Toxin-Antitoxin System.鲍曼不动杆菌 AbkAB 毒素-抗毒素系统菌株中耐受与持续机制的关系。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.00250-18. Print 2018 May.
8
Investigation of Colistin and Sulbactam Combination Effectivity in Multi Drug Resistant Acinetobacter baumannii Strains with Diagonal Gradient Strip Test Method.采用梯度纸条试验法研究多粘菌素与舒巴坦联合对多重耐药鲍曼不动杆菌菌株的有效性
Clin Lab. 2018 Oct 31;64(11). doi: 10.7754/Clin.Lab.2018.180508.
9
Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.碳青霉烯类耐药基因研究与多重耐药鲍曼不动杆菌的流行病学特征。
Microb Drug Resist. 2013 Apr;19(2):117-23. doi: 10.1089/mdr.2012.0049. Epub 2012 Jul 30.
10
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.首次检测到产GES-5碳青霉烯酶的鲍曼不动杆菌分离株。
Microb Drug Resist. 2017 Jul;23(5):556-562. doi: 10.1089/mdr.2016.0152. Epub 2016 Nov 17.
引用本文的文献
1
The global epidemiology of carbapenem-resistant .耐碳青霉烯类药物的全球流行病学情况
JAC Antimicrob Resist. 2025 Jul 29;7(4):dlaf134. doi: 10.1093/jacamr/dlaf134. eCollection 2025 Aug.
2
Evaluation of the in vitro activity of ampicillin-sulbactam and cefoperazone-sulbactam against A. Baumannii by the broth disk elution test.采用肉汤稀释法测定氨苄西林-舒巴坦和头孢哌酮-舒巴坦对鲍曼不动杆菌的体外活性。
Eur J Clin Microbiol Infect Dis. 2024 Sep;43(9):1711-1719. doi: 10.1007/s10096-024-04889-6. Epub 2024 Jul 6.
3
Distribution and molecular characterization of carbapenemase-producing gram-negative bacteria in Henan, China.中国河南产碳青霉烯酶的革兰氏阴性菌的分布及分子特征。
Sci Rep. 2024 Jun 22;14(1):14418. doi: 10.1038/s41598-024-65106-0.
4
Epidemiology, resistance genomics and susceptibility of species: results from the 2020 Spanish nationwide surveillance study.种的流行病学、耐药基因组学和易感性：来自 2020 年西班牙全国监测研究的结果。
Euro Surveill. 2024 Apr;29(15). doi: 10.2807/1560-7917.ES.2024.29.15.2300352.
5
Enzyme Patterns and Factors Associated with Mortality among Patients with Carbapenem Resistant (CRAB) Bacteremia: Real World Evidence from a Tertiary Center in India.碳青霉烯类耐药鲍曼不动杆菌（CRAB）血流感染患者的酶谱及与死亡率相关的因素：来自印度一家三级中心的真实世界证据
Indian J Crit Care Med. 2023 Sep;27(9):663-668. doi: 10.5005/jp-journals-10071-24534.
6
Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against .代谢组学揭示了舒巴坦、多粘菌素B和阿米卡星联合使用对……产生协同作用的机制。
Front Microbiol. 2023 Jun 29;14:1217270. doi: 10.3389/fmicb.2023.1217270. eCollection 2023.
7
Mutation in the two-component regulator BaeSR mediates cefiderocol resistance and enhances virulence in .突变的双组分调控器 BaeSR 介导头孢地尔耐药性，并增强 . 的毒力。
mSystems. 2023 Aug 31;8(4):e0129122. doi: 10.1128/msystems.01291-22. Epub 2023 Jun 22.
8
Alteration of Contributes to Tigecycline Resistance and Collateral Sensitivity to Sulbactam in Acinetobacter baumannii.改变导致鲍曼不动杆菌对替加环素耐药和对舒巴坦的交叉敏感性。
Microbiol Spectr. 2023 Jun 15;11(3):e0459422. doi: 10.1128/spectrum.04594-22. Epub 2023 May 15.
9
Phenotypic and Molecular Characteristics of Carbapenem-Resistant Isolates from Bulgarian Intensive Care Unit Patients.来自保加利亚重症监护病房患者的耐碳青霉烯类分离株的表型和分子特征
Microorganisms. 2023 Mar 29;11(4):875. doi: 10.3390/microorganisms11040875.
10
Computational exploration of molecular flexibility and interaction of meropenem analogs with the active site of oxacillinase-23 in .美罗培南类似物与23型苯唑西林酶活性位点的分子柔性及相互作用的计算探索
Front Chem. 2023 Feb 23;11:1090630. doi: 10.3389/fchem.2023.1090630. eCollection 2023.
本文引用的文献
1
Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China.中国不同遗传背景鲍曼不动杆菌分离株中舒巴坦耐药的分子流行病学和机制。
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.01947-17. Print 2018 Mar.
2
The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems.blaOXA-23 相关转座子存在于不动杆菌属基因组中，代表了该物种遭遇碳青霉烯类抗生素的流行病学情况。
J Antimicrob Chemother. 2017 Oct 1;72(10):2708-2714. doi: 10.1093/jac/dkx205.
3
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.不动杆菌感染的临床与病理生理学概述：一个世纪的挑战
Clin Microbiol Rev. 2017 Jan;30(1):409-447. doi: 10.1128/CMR.00058-16.
4
Multiplication of blaOXA-23 is common in clinical Acinetobacter baumannii, but does not enhance carbapenem resistance.blaOXA - 23基因在临床鲍曼不动杆菌中普遍存在，但不会增强对碳青霉烯类药物的耐药性。
J Antimicrob Chemother. 2016 Dec;71(12):3381-3385. doi: 10.1093/jac/dkw310. Epub 2016 Aug 5.
5
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014.2005 - 2014年中国细菌耐药性监测网（CHINET）报告的中国临床分离株耐药趋势。
Clin Microbiol Infect. 2016 Mar;22 Suppl 1:S9-14. doi: 10.1016/j.cmi.2016.01.001.
6
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study.2003年至2012年美国呼吸道和血流标本中鲍曼不动杆菌耐药性的长期趋势：一项调查研究。
J Hosp Med. 2016 Jan;11(1):21-6. doi: 10.1002/jhm.2477. Epub 2015 Sep 9.
7
Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii.鲍曼不动杆菌中不动杆菌来源的头孢菌素酶-30对舒巴坦耐药性的作用
Front Microbiol. 2015 Mar 25;6:231. doi: 10.3389/fmicb.2015.00231. eCollection 2015.
8
Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.鲍曼不动杆菌中舒巴坦抗菌活性及耐药决定因素的分子机制
Antimicrob Agents Chemother. 2015 Mar;59(3):1680-9. doi: 10.1128/AAC.04808-14. Epub 2015 Jan 5.
9
Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.类 D 碳青霉烯酶 OXA-23 和 OXA-146 的结构：对碳青霉烯类、头孢菌素类和氨曲南的作用机制基础。
Antimicrob Agents Chemother. 2013 Oct;57(10):4848-55. doi: 10.1128/AAC.00762-13. Epub 2013 Jul 22.
10
TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii.TEM-1β-内酰胺酶是鲍曼不动杆菌临床菌株对舒巴坦耐药的一个来源。
J Antimicrob Chemother. 2013 Dec;68(12):2786-91. doi: 10.1093/jac/dkt275. Epub 2013 Jul 9.
Zotero 插件